Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

15 ArticlesLupin

1 / 2

Q2-FY18: Earnings Notes: ICICI Lombard, Lupin & Mahindra CIE

Here is a short summary from the Q2-FY18 Earnings Call Transcript of a few selected stocks. The sole objective of this post is to provide a quick short digest ...

Earnings Report: 3QFY17 : 655 Companies Till Now With Management Comments!

Here is a quick summary of the 3QFY17 financial results for all the companies announced till date. For some companies, management comments have been reported ...

Lupin And Eli Lilly Expand Partnership For Eglucent® – Rapid-acting Insulin Analog Lispro

Lupin and Eli Lilly have announced a new partnership. The new agreement will allow Lupin to market and sell Eglucent®. Lupin will market and sell ...

FDA’s New Rules Propels Generic and Biosimilar Approvals

Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...

Lupin Goa Recalls 26,463 Bottles of Lisinopril Tablets and 3,192 Bottles Escitalopram Tablets

Drug major Lupin has initiated a recall of Escitalopram Tablets manufactured at its Goa facility (ANDA approcal received in September, 2012) which is a generic ...

Lupin Goa Recalls 55,348 Bottles of Tablets Used For The Treatment of High Blood Pressure & Chest Pain

Drug major Lupin Limited has initiated a recall of 55,348 bottles of Amlodipine Besylate Tablets. This recall has been initiated for the manufacturing ...

Lupin Profits Grow by 56%, gGlumetza Exclusivity Expires : Results Analysis

Lupin had a good numbers in terms of sales i.e  41% growth QoQ. The net profits saw a growth of 56% QoQ. Key Takeaways: Operating Margin went up from 22.92% ...

Lupin Acquires Branded Product Portfolio from Shionogi in Japan

Pharma Major Lupin Limited (Lupin) announced that its Japanese subsidiary Kyowa Pharmaceutical has entered into a strategic asset purchase agreement with ...

Lupin recalls 85,987 bottles of Lisinopril & Hydrochlorothiazide Tablets, second recall post EIR from USFDA

Drug major Lupin Pharmaceuticals Inc. (the US subsidiary of Lupin Pharmaceuticals), initiated a recall of Lisinopril & Hydrochlorothiazide Tables. ...

Lupin recalls 54,472 vials of Ceftriaxone, first recall post receipt of EIR from USFDA

Drug major Lupin Pharmaceuticals Inc. (the US subsidiary of Lupin Pharmaceuticals), initiated a recall of Ceftriaxone Sodium (Sterile) vials and the API ...